Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

OBJECTIVE: This trial evaluated the short-term safety and tolerability, steady-state pharmacokinetics, and preliminary efficacy of brivaracetam oral solution in children aged 1 month to < 16 years with epilepsy. METHODS: This was a phase IIa, open-label, single-arm, fixed three-step dose escalati...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Edwin, Dilley, Deanne, McDonough, Belinda, Stockis, Armel, Daniels, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682562/
https://www.ncbi.nlm.nih.gov/pubmed/31250322
http://dx.doi.org/10.1007/s40272-019-00332-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682562/
https://www.ncbi.nlm.nih.gov/pubmed/31250322
http://dx.doi.org/10.1007/s40272-019-00332-y

Ejemplares similares